Literature DB >> 10427619

Review: the oxidant/antioxidant balance during regular low density lipoprotein apheresis.

V Schettler1, H Methe, D Staschinsky, P Schuff-Werner, G A Müller, E Wieland.   

Abstract

Low density lipoprotein (LDL) apheresis is a safe procedure to treat severe hypercholesterolemia in patients with chronic heart disease (CHD). However, both hypercholesterolemia and extracorporeal treatment have been associated with oxidative stress. Even though LDL lowering has been proven to reduce CHD, the oxidative modification of LDL has been suggested to render these lipoproteins more atherogenic. It is therefore important to know whether LDL apheresis is safe with respect to oxidative stress including LDL oxidation. The contact of living cells such as leukocytes with artificial surfaces during extracorporeal treatment induces the liberation of various chemokines and cytokines as well as oxygen-derived radicals also known as respiratory burst. These effects justify the consideration of leukocyte activation resulting from extracorporeal treatment as an inflammatory reaction. In extracorporeal circuits such as those used for hemodialysis, the release of oxygen radicals has been shown and depends on the fiber material used in the dialyzer membranes. Reactive oxygen radicals can interact with different cell components such as carbohydrates, DNA, proteins, and lipids. Antioxidants in the form of low molecular weight molecules such as glutathione or radical scavenging enzymes such as superoxide dismutase offer protection against the damaging effects of prooxidants. The disturbed balance between prooxidants and antioxidants is considered as oxidative stress. Therefore, either an increase in oxygen radical formation or a decrease of antioxidants will lead to oxidative stress. During LDL apheresis, a decrease of low molecular weight antioxidants has been reported. In contrast, we have observed an increase in plasma glutathione concentrations but no severe reduction in the activity of antioxidant enzymes in plasma, red cells, or granulocytes, which may explain the lack of plasma lipid peroxidation shown during this kind of extracorporeal treatment. In addition, LDL isolated at the end of apheresis procedures are more resistant to oxidation. These findings suggest that LDL apheresis is safe with respect to radical mediated injury.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10427619     DOI: 10.1111/j.1091-6660.1999.t01-3-.x

Source DB:  PubMed          Journal:  Ther Apher        ISSN: 1091-6660


  11 in total

1.  Low-density lipoprotein (LDL) apheresis reduces atherogenic and oxidative markers in uremic patients with hyperlipidemia.

Authors:  Tung-Sheng Chen; Show-Yih Liou; Hsi-Chin Wu; Fuu-Jen Tsai; Chang-Hai Tsai; Chih-Yang Huang; Yen-Lin Chang
Journal:  Int Urol Nephrol       Date:  2010-03-14       Impact factor: 2.370

2.  Protective effect of luteolin in experimental ischemic stroke: upregulated SOD1, CAT, Bcl-2 and claudin-5, down-regulated MDA and Bax expression.

Authors:  Huimin Qiao; Lipeng Dong; Xiangjian Zhang; Chunhua Zhu; Xiaolin Zhang; Lina Wang; Zongjie Liu; Linyu Chen; Yinxue Xing; Chaohui Wang; Yanhua Li
Journal:  Neurochem Res       Date:  2012-06-14       Impact factor: 3.996

3.  Alpha-Lipoic Acid Attenuates MPTP/MPP+-Induced Neurotoxicity: Roles of SIRT1-Dependent PGC-1α Signaling Pathways.

Authors:  Jian Zhang; Ya Gao; Lan Zhang; Cong Zhang; Yuan Zhao; Yidan Zhang; Shuyue Li; Cui Chang; Xiangjian Zhang; Guofeng Yang
Journal:  Neurotox Res       Date:  2022-02-11       Impact factor: 3.911

4.  Cardioprotective effects and mechanism of Radix Salviae miltiorrhizae and Lignum Dalbergiae odoriferae on rat myocardial ischemia/reperfusion injury.

Authors:  Fei Mu; Jialin Duan; Haixu Bian; Ying Yin; Yanrong Zhu; Guo Wei; Yue Guan; Yanhua Wang; Chao Guo; Aidong Wen; Yong Yang; Miaomiao Xi
Journal:  Mol Med Rep       Date:  2017-06-20       Impact factor: 2.952

5.  Rhein protects against cerebral ischemic‑/reperfusion‑induced oxidative stress and apoptosis in rats.

Authors:  Qipeng Zhao; Xiaobo Wang; Ailing Chen; Xiuli Cheng; Guoxin Zhang; Jianmin Sun; Yunsheng Zhao; Yu Huang; Yafei Zhu
Journal:  Int J Mol Med       Date:  2018-02-13       Impact factor: 4.101

6.  The effect of rosmarinic acid on deformities occurring in brain tissue by craniectomy method. Histopathological evaluation of IBA-1 and GFAP expressions.

Authors:  Hüseyin Özevren; Engin Deveci; Mehmet Cudi Tuncer
Journal:  Acta Cir Bras       Date:  2020-06-19       Impact factor: 1.388

7.  Rosmarinic acid elicits neuroprotection in ischemic stroke via Nrf2 and heme oxygenase 1 signaling.

Authors:  Hai-Ying Cui; Xiang-Jian Zhang; Yi Yang; Cong Zhang; Chun-Hua Zhu; Jiang-Yong Miao; Rong Chen
Journal:  Neural Regen Res       Date:  2018-12       Impact factor: 5.135

8.  Metabonomic strategy to the evaluation of chinese medicine compound danshen dripping pills interfering myocardial ischemia in rats.

Authors:  Xue Xin; Haimiao Zou; Ningning Zheng; Xinchun Xu; Yinmin Liu; Xiaoxian Wang; Hongbing Wu; Lina Lu; Jing Su; Mingfeng Qiu; Xiaoyan Wang
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-02       Impact factor: 2.629

9.  Total and corrected antioxidant capacity in hemodialyzed patients.

Authors:  Niki Malliaraki; Dimitris Mpliamplias; Marilena Kampa; Kostas Perakis; Andrew N Margioris; Elias Castanas
Journal:  BMC Nephrol       Date:  2003-07-01       Impact factor: 2.388

10.  Neuroprotective effects of curdione against focal cerebral ischemia reperfusion injury in rats.

Authors:  Xing-Jie Li; Li Liang; Hong-Xia Shi; Xiao-Ping Sun; Jing Wang; Lian-Sheng Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2017-06-30       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.